Literature DB >> 28549900

Four decades of ocular renin-angiotensin and kallikrein-kinin systems (1977-2017).

Rajko Igić1.   

Abstract

This review offers a contemporary history of the renin-angiotensin (RAS) and kallikrein-kinin (KKS) systems with emphasis on how these complex systems affect the eye. It describes the types of communication (cross-talk) between the two systems and evaluates their potential role in the development of diabetic retinopathy, diabetic macular edema, age-related macular degeneration, glaucoma, and uveitis. In addition to detailing the important physiological actions of components of the RAS and KKS, possibilities are suggested for new therapeutic avenues in the treatment of common ocular diseases. Historical notes indicate the major events in this research area, marking four decades from the first publication on the discovery of renin and angiotensin converting enzyme in the eye to the present time.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Age-related macular degeneration; Cataract; Diabetic macular edema; Diabetic retinopathy; Glaucoma; Kallikrein-kinin system; Renin-angiotensin system; Uveitis

Mesh:

Year:  2017        PMID: 28549900     DOI: 10.1016/j.exer.2017.05.007

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  5 in total

1.  An exploration of bioactive peptides: My collaboration with Ervin G. Erdös.

Authors:  Rajko Igić
Journal:  J Biol Chem       Date:  2018-05-25       Impact factor: 5.157

2.  Local ocular renin-angiotensin-aldosterone system: any connection with intraocular pressure? A comprehensive review.

Authors:  Mervi Holappa; Heikki Vapaatalo; Anu Vaajanen
Journal:  Ann Med       Date:  2020-04-30       Impact factor: 4.709

3.  Urinary Kallidinogenase plus rt-PA Intravenous Thrombolysis for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Jing Wu; Jiang Wu; Le Wang; Jinmin Liu
Journal:  Comput Math Methods Med       Date:  2022-05-17       Impact factor: 2.809

Review 4.  Therapeutic Values of Human Urinary Kallidinogenase on Cerebrovascular Diseases.

Authors:  Zhenyu Wei; Yi Lyu; XiaoLi Yang; Xin Chen; Ping Zhong; Danhong Wu
Journal:  Front Neurol       Date:  2018-06-05       Impact factor: 4.003

5.  Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-Ay/J and high-fat diet/streptozotocin-induced mouse models of type 2 diabetes.

Authors:  Ying Cheng; Xiaochen Yu; Jie Zhang; Yunpeng Chang; Mei Xue; Xiaoyu Li; Yunhong Lu; Ting Li; Ziyu Meng; Long Su; Bei Sun; Liming Chen
Journal:  Diabetologia       Date:  2019-03-05       Impact factor: 10.122

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.